Trump administration approves delay in FDA e-cigs guidelines
Brad Rodu, a professor of medicine at the University of Louisville and an anti-smoking advocate, said the announcement “has been falsely portrayed as a public health setback.”
“Instead, it is evidence that officials at those agencies recognize that the deeming regulation is a public health travesty that defies the FDA’s fundamental principles.”
Featured Publications
Spotlight on Criminal Justice: Supporting Law Enforcement and Safer Communities – May
More Spectrum, Please
How Trump’s “10-to-1” Deregulation Initiative Is Taking Shape in Financial Services
Safer Solutions: Why Focusing Exclusively On Drug Supply Isn’t Enough
Prosecutors' Case for Survivor Sentencing Laws